Abstracts

Platform-Psychosocial

Association between Cognition and Social Role Participation Among Patients with Multiple Sclerosis

Background: Multiple sclerosis (MS), a relapsing and progressive demyelinating disease of the central nervous system, results in impaired...

Read More

Platform-Disease Management

Prevalence of Cannabis Use and Associated Factors Among People with Multiple Sclerosis: A 2020 NARCOMS Survey

Background: The North American Research Committee on Multiple Sclerosis (NARCOMS) registry is a voluntary, self-report registry for people...

Read More

Platform-Rehabilitation

Using Seating and Wheeled Mobility to Manage MS Symptoms

Background: Advances in seating and wheeled mobility technology can benefit the MS community, facilitating more independence with mobility...

Read More

Platform-Disease Modifying Therapies

COVID-19 Vaccine Response in People with MS Treated with Dimethyl Fumarate, Diroximel Fumarate, Natalizumab, Ocrelizumab or Interferon Therapy

Background: COVID-19 is a potentially fatal respiratory illness, caused by the novel coronavirus, SARS-CoV-2, which developed into the...

Read More

Platform-Rehabilitation

Spasticity Experience in Adults with Multiple Sclerosis: An Integrated Conceptual Model

Background: Spasticity is a common symptom of multiple sclerosis (MS), often leading to functional limitations and disability. Objectives:...

Read More

Platform-Psychosocial

Exploring the Impact of the COVID-19 Pandemic on Social Isolation and Mental Health in People with MS

Background: People with Multiple Sclerosis (MS) may be disproportionally impacted by COVID-19 as various factors important to their...

Read More

Platform-Disease Management

Optical Coherence Tomography As a Biomarker for Multiple Sclerosis Studies

Background: Optic Neuritis occurs in about 20% of MS patients as the initial symptom. Objectives: To assess the clinical utility of optical...

Read More